Condition: Sarcoma
Interventions: Genetic: mutation analysis; Genetic: nucleic acid sequencing; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified April 2012
Feeds
4580 items (4580 unread) in 80 feeds
Acinar Cell Carcinoma
(28 unread)
Acinic Cell Carcinoma
(32 unread)
Adenoid Cystic Carcinoma
(56 unread)
Adrenal Gland Cancer
(327 unread)
Ampulla Of Vater
(14 unread)
Anal Cancer
(252 unread)
Angiosarcoma
(72 unread)
Appendix Cancer
(34 unread)
Bile Duct Cancer
(385 unread)
Brain and CNS
(1133 unread)
Carcinoid
(143 unread)
Endocrine/Neuroendocrine
(291 unread)
Gall Bladder Cancer
(223 unread)
Hemangioendothelioma
(23 unread)
Hepatoblastoma
(30 unread)
Pancreas
(45 unread)
Phyllodes
(21 unread)
PMP and Mucinous Tumors
(19 unread)
Rhabdomyosarcoma
(186 unread)
Sarcoma
(600 unread)
Twitter Pals
(666 unread)
Trial - Rhabdomyosarcoma (12 unread)
-
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
Posted: April 24th, 2012, 8:00am MDT
-
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
Posted: April 23rd, 2012, 8:00am MDT
Conditions: Adult Rhabdomyosarcoma; Lung Metastases; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Previously Treated Childhood Rhabdomyosarcoma; Recurrent Adult Soft Tissue Sarcoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Stage IV Adult Soft Tissue Sarcoma; Stage IV Wilms Tumor; Stage V Wilms Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Radiation: intensity-modulated radiation therapy
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified April 2012 -
PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma
Posted: April 18th, 2012, 8:00am MDT
Condition: Ewing Family of Tumors, Rhabdomyosarcoma
Intervention: Drug: Lipegfilgrastim
Sponsors: Teva Pharmaceutical Industries; Merckle GmbH
Not yet recruiting - verified May 2012 -
Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma : International Randomized Trial
Posted: May 16th, 2011, 8:00am MDT
Condition: RHABDOMYOSARCOMA
Interventions: Drug: Vincristine, Irinotecan; Drug: Vincristine-Irinotecan-Temozolomide
Sponsors: Centre Oscar Lambret; Centre Oscar Lambret; SFCE
Recruiting - verified May 2012 -
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Posted: January 13th, 2010, 8:00am MST
Conditions: Adrenocortical Carcinoma; Gastrointestinal Carcinoid Tumor; Kidney Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
Interventions: Biological: Seneca Valley virus-001; Drug: cyclophosphamide; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 -
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
Posted: May 9th, 2009, 8:00am MDT
Condition: Lymphoma
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Active, not recruiting - verified May 2012 -
Combination Chemotherapy in Treating Patients With Sarcoma
Posted: April 18th, 2008, 8:00am MDT
Conditions: Ovarian Cancer; Sarcoma
Interventions: Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: vincristine sulfate; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy; Procedure: therapeutic conventional surgery; Radiation: brachytherapy; Radiation: intraoperative radiation therapy; Radiation: radiation therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Active, not recruiting - verified May 2012 -
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Posted: April 7th, 2004, 8:00am MDT
Conditions: Kidney Cancer; Leukemia; Lymphoma; Neuroblastoma; Oral Complications; Sarcoma
Intervention: Dietary Supplement: Traumeel S
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010 -
Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Posted: July 8th, 2003, 8:00am MDT
Condition: Sarcoma
Intervention: Drug: soblidotin
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; National Cancer Institute (NCI)
Completed - verified May 2012 -
Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
Posted: March 6th, 2003, 8:00am MST
Condition: Sarcoma
Intervention: Drug: exatecan mesylate
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Completed - verified May 2012 -
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
Posted: November 1st, 1999, 8:00am MST
Condition: Sarcoma
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: ifosfamide; Drug: melphalan; Procedure: peripheral blood stem cell transplantation
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Active, not recruiting - verified May 2012 -
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Posted: November 1st, 1999, 8:00am MST
Condition: Sarcoma
Interventions: Biological: dactinomycin; Biological: filgrastim; Biological: sargramostim; Drug: cyclophosphamide; Drug: vincristine sulfate; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010